Melhus Sparebank
OSE:MELG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Melhus Sparebank
OSE:MELG
|
NO |
|
Oxford BioMedica PLC
LSE:OXB
|
UK |
|
T
|
Talenthouse AG
SIX:THAG
|
CH |
|
LAVA Therapeutics NV
NASDAQ:LVTX
|
NL |
|
Japfa Comfeed Indonesia Tbk PT
IDX:JPFA
|
ID |
|
Itway SpA
MIL:ITW
|
IT |
|
West African Resources Ltd
ASX:WAF
|
AU |
|
Argus Shanghai Textile Chemicals Co Ltd
SSE:603790
|
CN |
|
F
|
FinanzaTech SpA SB
MIL:FTC
|
IT |
|
Shoulder Innovations Inc
NYSE:SI
|
US |
Wall Street
Price Targets
MELG Price Targets Summary
Melhus Sparebank
According to Wall Street analysts, the average 1-year price target for
MELG
is 204 NOK
with a low forecast of 202 NOK and a high forecast of 210 NOK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MELG's stock price target?
Price Target
204
NOK
According to Wall Street analysts, the average 1-year price target for
MELG
is 204 NOK
with a low forecast of 202 NOK and a high forecast of 210 NOK.
What is Melhus Sparebank's Revenue forecast?
Projected CAGR
1%
For the last 14 years the
compound annual growth rate for
Melhus Sparebank's revenue is
9%.
The projected
CAGR
for the next 2 years is
1%.
What is Melhus Sparebank's Net Income forecast?
Projected CAGR
-3%
For the last 14 years the
compound annual growth rate for
Melhus Sparebank's net income is
3%.
The projected
CAGR
for the next 2 years is
-3%.
